2025
Percutaneous Cryoablation of Non-small Cell Lung Cancer in Patients with Recurrence After Stereotactic Body Radiation Therapy
Fish A, Park H, Knight E, Knowlton C, Madoff D. Percutaneous Cryoablation of Non-small Cell Lung Cancer in Patients with Recurrence After Stereotactic Body Radiation Therapy. CardioVascular And Interventional Radiology 2025, 48: 626-632. PMID: 40069339, DOI: 10.1007/s00270-025-04002-0.Peer-Reviewed Original ResearchConceptsStereotactic body radiation therapyNon-small cell lung cancerCell lung cancerProgression-free survivalLung cancerPercutaneous cryoablationRadiation therapyOverall survivalTechnical successLocal controlNon-small cell lung cancer recurrenceHome oxygen requirementPost-procedure hospitalizationHistory of smokingWorsening pulmonary functionPost-procedural pneumothoraxEffective treatment alternativeConclusionPercutaneous cryoablationCryoablation protocolResults29 patientsTarget tumorsAdverse eventsCryoablationPulmonary functionLesion size
2013
Evaluation of YO-PRO-1 as an early marker of apoptosis following radiofrequency ablation of colon cancer liver metastases
Fujisawa S, Romin Y, Barlas A, Petrovic L, Turkekul M, Fan N, Xu K, Garcia A, Monette S, Klimstra D, Erinjeri J, Solomon S, Manova-Todorova K, Sofocleous C. Evaluation of YO-PRO-1 as an early marker of apoptosis following radiofrequency ablation of colon cancer liver metastases. Cytotechnology 2013, 66: 259-273. PMID: 24065619, PMCID: PMC3918265, DOI: 10.1007/s10616-013-9565-3.Peer-Reviewed Original ResearchColorectal-cancer liver metastasesYO-PRO-1Liver metastasesColon cancer liver metastasisLiver tissuePropidium iodineCancer liver metastasesMouse liverMarkers of cell deathMinimally invasive treatmentMouse liver parenchymaSurrounding liver tissueMarkers of apoptosisSurgical resectionPlasma membrane injuryRadiofrequency ablationDynamic CTPI signalingNonsurgical patientsPathological examinationTarget tumorsInvasive treatmentPositive cellsBiopsy samplesNormal mouse liver
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply